cgp 12177 has been researched along with Hyperglycemia in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thackeray, JT | 1 |
| Parsa-Nezhad, M | 1 |
| Kenk, M | 1 |
| Thorn, SL | 1 |
| Kolajova, M | 1 |
| Beanlands, RS | 1 |
| DaSilva, JN | 1 |
1 other study available for cgp 12177 and Hyperglycemia
| Article | Year |
|---|---|
Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Experimental | 2011 |